EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Keishikaryukotsuboreito Potentiates NGF-Induced Neurite Outgrowth in PC12 Cells

Kazuki Terada iD, Yukari Matsushima, Makoto Hosoyamada iD

Life · 05.03.2026 · 16 (3) · 423

DOI: 10.3390/life16030423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life, online erschienen am 05.03.2026. Verfasst von Kazuki Terada und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Physiology and Pathology, Faculty of Pharmaceutical Sciences, Teikyo University, Tokyo 173-8605, Japan. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Society for the Promotion of Science KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Keishikaryukotsuboreito (KKT) is a Kampo formula prescribed for neuropsychiatric symptoms, whereas Keishito (KT), despite including most of the constituent herbs, is not indicated for such conditions, suggesting distinct biological actions. We examined whether KT and KKT modulate nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells. Cells were stimulated with NGF in the presence or absence of KT or KKT, and neurite extension was quantified. The involvement of NGF receptor signaling was assessed using the Trk inhibitor K-252a. KKT, but not KT, enhanced NGF-induced neurite outgrowth in a concentration-dependent manner without affecting basal morphology. Pharmacological analysis showed that KKT increased the maximal NGF-induced neurite response (Emax) without altering NGF potency (EC50). K-252a completely abolished NGF-induced neurite extension and KKT-mediated enhancement, indicating that the effect was entirely dependent on NGF–TrkA signaling. These findings demonstrate that KKT selectively augments NGF-elicited neuronal differentiation and suggest translational relevance as a neurotrophic strategy.

Schlagwörter

Stichwörter der Autor:innen

Kampo medicineKeishikaryukotsuboreitoKeishitonerve growth factorneurite outgrowth

Autor:innen und Institutionen

  • Laboratory of Human Physiology and Pathology, Faculty of Pharmaceutical Sciences, Teikyo University, Tokyo 173-8605, Japan.
  • Ginza Research Center, Mirailab Bioscience Inc., Tokyo 104-0061, Japan.

ORCID-Profile: Kazuki Terada, Makoto Hosoyamada

Förderung

  • Japan Society for the Promotion of Science
  • Japan Society for the Promotion of Science KAKENHI

Zitieren

APA

Terada, K., Matsushima, Y., & Hosoyamada, M. (2026). Keishikaryukotsuboreito Potentiates NGF-Induced Neurite Outgrowth in PC12 Cells. Life, 16(3), 423. https://doi.org/10.3390/life16030423

Vancouver

Terada K, Matsushima Y, Hosoyamada M. Keishikaryukotsuboreito Potentiates NGF-Induced Neurite Outgrowth in PC12 Cells. Life. 2026;16(3):423. doi:10.3390/life16030423

BibTeX
@article{Terada2026,
  author = {Terada, Kazuki and Matsushima, Yukari and Hosoyamada, Makoto},
  title = {Keishikaryukotsuboreito Potentiates NGF-Induced Neurite Outgrowth in PC12 Cells},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {423},
  doi = {10.3390/life16030423}
}
Kostenlos starten →